ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 774

Identical T Cell Clones Identified over Time in the Joints of Oligoarticular Juvenile Idiopathic Arthritis Patients

Amelie Jule1, Kacie Hoyt 2, Margaret Chang 3, Fatma Dedeoglu 2, Melissa Hazen 1, Peter Nigrovic 4 and Lauren Henderson 1, 1Boston Children's Hospital, Boston, MA, 2Boston Children's Hospital, Boston, 3Division of Immunology, Boston Children's Hospital, Boston, 4Department of Medicine, Division of Rheumatology, Immunology and Allergy, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA ; Department of Medicine, Division of Immunology, Boston Children’s Hospital, Harvard Medical School, Boston, MA, USA., Boston

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: juvenile idiopathic arthritis (JIA) and T cell repertoire

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 10, 2019

Title: Pediatric Rheumatology – ePoster I: Basic Science, Biomarkers, & Sclerodermic Fever

Session Type: Poster Session (Sunday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Oligoarticular juvenile idiopathic arthritis (oligo JIA) is characterized by arthritis in a few joints (fewer than 5) with recurrent flares of inflammation, often in the same joint distribution.  The mechanisms driving site-specific inflammation in oligo JIA remain unknown.  Previous evaluations of the T cell receptor beta (TCRB) repertoire in oligo JIA patients revealed clonotypic expansion among CD4+ effector and regulatory T cell populations obtained from the synovial fluid (SF).  We aimed to further delineate the dynamics of the T cell repertoire in the arthritic joints of oligo JIA patients longitudinally.

Methods: SF samples were collected from 3 oligo JIA patients, defined by ILAR criteria, at 2 timepoints.  Serial samples were taken from the same affected joint in a given patient.  Peripheral blood (PB) from 7 healthy donors was also collected.  DNA was extracted from sorted regulatory (CD4+CD25+CD127lo, Treg), effector (CD4+CD25–, Teff), and CD8+ T cells.  The TCRB complementarity determining region 3 (CDR3) was amplified by multiplex PCR and sequenced using the Illumina HiSeq platform (Adaptive Biotechnologies).  Data was analyzed with VDJtools 1.2.1 and R 3.5.1.

Results: 3 oligo JIA patients (1 male and 2 females) with an average age of 6.4 years were studied.  SF was collected from the knee joint in all cases.  At baseline (T1), no patient was treated with immunosuppressive medications; however, at the second timepoint (T2), all were taking disease-modifying antirheumatic drugs.  The SF sample at T2 was on average 17.3 months after the sample at T1.  The SF Treg, Teff, and CD8+ TCRB repertoires were more clonal than those of the respective T cell population in the PB of controls.  There was no substantial variation over time in the clonality of Treg, Teff, and CD8+ T cell populations from serial SF samples.  In an individual patient, there was overlap in the amino acid sequences of the TCRB CDR3 at T1 and T2: on average, 18%, 19% and 8% of the clonotypes were the same at T1 and T2, respectively for Treg, Teff, and CD8+ T cell repertoires.  TCR clones that reoccurred over time tended to be more clonally expanded than TCR clones that occurred at only one timepoint, with frequencies of shared clones being 2-, 3-, and 5-fold larger on average, respectively in Treg, Teff and CD8+ T cells.  Sharing of clones across patients was identified more frequently in Treg and CD8+ T cell than Teff cells.

Conclusion: Flares of arthritis in oligo JIA were characterized by resurgence of the same TCR clones longitudinally.  There was also sharing of TCR clonotypes in Treg and CD8+ T cells across oligo JIA patients.  These findings suggest that pathogenic clones, potentially recognizing similar antigens, may persist in the joints of oligo JIA patients and drive disease over time.  While recurring clones may be recruited to the joint with each flare, the extent of repertoire overlap suggests a resident phenotype.  Further work is ongoing to characterize the physicochemical properties of shared and clonally expanded clones, and to determine whether they are resident in the affected joints.


Disclosure: A. Jule, None; K. Hoyt, None; M. Chang, None; F. Dedeoglu, None; M. Hazen, None; P. Nigrovic, None; L. Henderson, None.

To cite this abstract in AMA style:

Jule A, Hoyt K, Chang M, Dedeoglu F, Hazen M, Nigrovic P, Henderson L. Identical T Cell Clones Identified over Time in the Joints of Oligoarticular Juvenile Idiopathic Arthritis Patients [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/identical-t-cell-clones-identified-over-time-in-the-joints-of-oligoarticular-juvenile-idiopathic-arthritis-patients/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/identical-t-cell-clones-identified-over-time-in-the-joints-of-oligoarticular-juvenile-idiopathic-arthritis-patients/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology